Cover Image

A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Zhang, Cong, Long, Meihua, Zheng, Tianyu, Sechidis, Konstantinos, Liu, Xiaoni, Sun, Sophie, Chen, Yao, Zhang, Xinyi, Kaneko, Shuhei, Bornkamp, Björn, Hou, Yan
Format:	Preprint
Published:	2026
Subjects:	Applications Methodology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity
by: Sechidis, Konstantinos, et al.
Published: (2025)

WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
by: Sechidis, Konstantinos, et al.
Published: (2024)

Comparing methods to assess treatment effect heterogeneity in general parametric regression models
by: Chen, Yao, et al.
Published: (2025)

Assessment of evidence against homogeneity in exhaustive subgroup treatment effect plots
by: Bornkamp, Björn, et al.
Published: (2026)

Evaluating causal effects on time-to-event outcomes in an RCT in Oncology with treatment discontinuation
by: Ballerini, Veronica, et al.
Published: (2023)

Data-driven controlled subgroup selection in clinical trials
by: Müller, Manuel M., et al.
Published: (2025)

Futility analyses for the MCP-Mod methodology based on longitudinal models
by: Bornkamp, Björn, et al.
Published: (2024)

Uncovering Treatment Effect Heterogeneity in Pragmatic Gerontology Trials
by: Li, Changjun, et al.
Published: (2025)

Statistical Inference for Heterogeneous Treatment Effect with Right-censored Data from Synthesizing Randomized Clinical Trials and Real-world Data
by: Mao, Guangcai, et al.
Published: (2025)

Heterogeneous Clinical Trial Outcomes via Multi-Output Gaussian Processes
by: Thomas, Owen, et al.
Published: (2024)

Using Individualized Treatment Effects to Assess Treatment Effect Heterogeneity
by: Konstantinos Sechidis, et al.
Published: (2025)

Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population
by: Zhang, Hong, et al.
Published: (2023)

Identifying Treatment Effect Heterogeneity with Bayesian Hierarchical Adjustable Random Partition in Adaptive Enrichment Trials
by: Zhao, Xianglin, et al.
Published: (2025)

A Mixed Model Approach for Estimating Regional Functional Connectivity from Voxel-level BOLD Signals
by: Liu, Ruobin, et al.
Published: (2022)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
by: Komaki, Moka, et al.
Published: (2025)

WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial Sponsors
by: Konstantinos Sechidis, et al.
Published: (2024)

Eligibility-Aware Evidence Synthesis: An Agentic Framework for Clinical Trial Meta-Analysis
by: Zhao, Yao, et al.
Published: (2026)

Comparing Methods to Assess Treatment Effect Heterogeneity in General Parametric Regression Models
by: Yao Chen, et al.
Published: (2026)

Correcting for Missing Data When Evaluating Surrogate Markers in a Clinical Trial
by: Lotspeich, Sarah C., et al.
Published: (2026)

Correcting for confounding in longitudinal experiments: positioning non-linear mixed effects modeling as implementation of standardization using latent conditional exchangeability
by: Bartels, Christian, et al.
Published: (2024)

Treatment Effect Heterogeneity and Importance Measures for Multivariate Continuous Treatments
by: Shin, Heejun, et al.
Published: (2024)

A Bayesian Discrete Framework for Enhancing Decision-Making Processes in Clinical Trial Designs and Evaluations
by: Pramanik, Paramahansa, et al.
Published: (2026)

Assessing Heterogeneity of Treatment Effects
by: Kaji, Tetsuya, et al.
Published: (2023)

A Clustering Approach for Basket Trials Based on Treatment Response Trajectories
by: Kojima, Masahiro, et al.
Published: (2025)

On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials
by: Yang, Peng, et al.
Published: (2026)

[Invited Discussion] Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
by: Phillips, Rachael V., et al.
Published: (2024)

E-values for Adaptive Clinical Trials: Anytime-Valid Monitoring in Practice
by: Sokolova, Alexandra, et al.
Published: (2026)

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials
by: Maity, Arnab Kumar, et al.
Published: (2024)

A Causal Machine Learning Framework for Treatment Personalization in Clinical Trials: Application to Ulcerative Colitis
by: Minoccheri, Cristian, et al.
Published: (2026)

Statistical Considerations for Evaluating Treatment Effect under Various Non-proportional Hazard Scenarios
by: Zhang, Xinyu, et al.
Published: (2024)

Estimating Heterogeneous Causal Effects of High-Dimensional Treatments: Application to Conjoint Analysis
by: Goplerud, Max, et al.
Published: (2022)

Shifting the Paradigm: Estimating Heterogeneous Treatment Effects in the Development of Walkable Cities Design
by: Zhu, Jie, et al.
Published: (2024)

Estimating Interpretable Heterogeneous Treatment Effect with Causal Subgroup Discovery in Survival Outcomes
by: Bo, Na, et al.
Published: (2024)

Precision Mental Health: Predicting Heterogeneous Treatment Effects for Depression through Data Integration
by: Brantner, Carly L., et al.
Published: (2025)

Dynamic Prediction of the Target Survival Time in Metastatic Solid Tumor Cancer Clinical Trials
by: Wang, Sidi, et al.
Published: (2026)

Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
by: Sunami, Hisato, et al.
Published: (2024)

Practical Process Capability Indices Workflows
by: Jiang, Fei, et al.
Published: (2026)

SIMBA -- A Bayesian Decision Framework for the Identification of Optimal Biomarker Subgroups for Cancer Basket Clinical Trials
by: Yuan, Shijie, et al.
Published: (2025)

Priors from Envisioned Posterior Judgments: A Novel Elicitation Approach With Application to Bayesian Clinical Trials
by: Ouyang, Yongdong, et al.
Published: (2024)

BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
by: Zhu, Di, et al.
Published: (2026)